// App-Quantinova.ai

e13083 : Initiation and adherence with bone-targeting agents in US men with bone metastases from prostate cancer.

Researchers

Presenter

  • Alexander Liede

Principal Investigators

  • Anne M. Butler

  • Karynsa Cetin

  • Rohini K Hernandez

  • Robert Overman

  • Jung In Kim

  • B. Diane Reams

  • Bradford Richard Hirsch

  • Amy Pickar Abernethy

  • M. Alan Brookhart

Medical Centers

  • Amgen Inc, South San Francisco, CA

  • University of North Carolina, Chapel Hill, NC

  • Center for Observational Research, Amgen, Inc., Thousand Oaks, CA

  • Amgen Inc, Thousand Oaks, CA

  • Flatiron Health, New York, NY

  • Duke University Medical Center, Duke Cancer Institute, Durham, NC

Locations

  • United States

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Bone metastases

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved